A Clinical Association between an Increasing Renal Resistive Index and the Atherosclerotic Burden in Patients with a

Ippei Watanabe1, Yodo Shintani2, Shigenori Terada3

  • 1Department of Cardiovascular Medicine, Toho University School of Medicine, Japan.

Insights

The renal resistive index (RRI) can identify atherosclerosis in patients without kidney disease. Higher RRI values correlate with more extensive arterial plaque, serving as an early atherosclerosis marker.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Imaging

Background:

  • Cardiovascular disease risk increases with renal impairment.
  • The renal resistive index (RRI) is a measure of renal vascular resistance.
  • Early detection of atherosclerosis is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To investigate the relationship between RRI and atherosclerosis extent in patients without renal impairment.
  • To determine if RRI can serve as a marker for sub-clinical atherosclerosis.

Main Methods:

  • 106 outpatients with estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m² underwent coronary computed tomography angiography (CCTA) and carotid artery ultrasound.
  • Renal resistive index (RRI) was measured pre-procedurally.
  • Atherosclerosis extent was defined by coronary artery calcium (CAC) >0 and carotid intima-media thickness (cIMT) ≥1.0 mm.

Main Results:

  • Multi-site atherosclerosis was identified in 31 patients.
  • RRI was significantly higher in patients with multi-site atherosclerosis (0.71±0.05) compared to those with no (0.65±0.04) or single-site (0.67±0.06) atherosclerosis (p<0.001).
  • RRI > 0.70 was independently associated with multi-site atherosclerosis (OR: 4.05, p=0.01).

Conclusions:

  • The renal resistive index (RRI) is a valuable marker for sub-clinical atherosclerosis in individuals without renal impairment.
  • RRI may aid in identifying patients at higher cardiovascular risk who have normal kidney function.
  • Further research can explore RRI's role in predicting cardiovascular events.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
785
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
375
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
353
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
270
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
816